CL King downgraded ShockWave Medical to Neutral from Buy with a $335 price target after the company entered into an agreement under which Johnson & Johnson (JNJ) will acquire it for $335 per share in cash.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SWAV:
- ShockWave Medical downgraded to Market Perform from Outperform at Leerink
- ShockWave Medical downgraded to Hold from Buy at Canaccord
- ShockWave Medical downgraded to Neutral from Overweight at Piper Sandler
- Krispy Kreme upgraded, Altice USA downgraded: Wall Street’s top analyst calls
- M&A News: Johnson & Johnson (NYSE:JNJ) Enters Into $13.1B Shockwave Medical Deal